BTX stock news

BioTime (BTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
BioTime, Inc. (NYSEMKT:BTX) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Ioana Hone - Director of Investor Relations Brian Cull Read more
BioTime (BTX) delivered earnings and revenue surprises of 600.00% and 40.61%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Read more

BioTime EPS of $0.30

08:51pm, Thursday, 09'th May 2019
Read more
BioTime (BTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
The following slide deck was published by BioTime, Inc. in conjunction with this event. Read more
BioTime (BTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). Read more
Celsion Corporation (NASDAQ:CLSN) and BioTime Inc. (NYSEAMERICAN:BTX) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as pr Read more
Based on the lastest quarterly filings, institutions continue to be large stakeholders in BioTime, Inc. (:BTX). The big banks are holding 38.40% of the shares while company insiders are clinging to 0. Read more
ADMA Biologics Inc. (NASDAQ:ADMA) and BioTime Inc. (NYSEAMERICAN:BTX), both competing one another are Biotechnology companies. We will contrast their dividends, analyst recommendations, profitability, Read more
We are comparing ProQR Therapeutics N.V. (NASDAQ:PRQR) and BioTime Inc. (NYSEAMERICAN:BTX) on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valua Read more
The Earnings to Price yield of Marchex, Inc. (NasdaqGS:MCHX) is -0.013660. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the most Read more
As we move closer towards the end of the year, investors might be looking over the portfolio and trying to see what has been working and what hasn’t been. Investors may be studying the most recent e Read more
Wall Street brokerages expect that BioTime, Inc. (NASDAQ:BTX) will announce sales of $530,000.00 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estim Read more
We will be comparing the differences between Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) and BioTime Inc. (NYSEAMERICAN:BTX) as far as profitability, analyst recommendations, risk, institutional owners Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT